Evidence map›Paper›PMID 38074730›Full record

ArticleFrontiers in public health2023

Stakeholders' views and opinions on existing guidelines on "How to Choose Mental Health Apps".

Wishah Khan, Bertina Jebanesan, Sarah Ahmed, Chris Trimmer, Branka Agic, Farhana Safa, Aamna Ashraf, Andrew Tuck, Kelsey Kavic, Sapna Wadhawan and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Wishah KhanCentre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Bertina JebanesanCentre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Sarah AhmedCentre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Chris TrimmerCentre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Branka AgicCentre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Farhana SafaCentre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Aamna AshrafCentre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Andrew TuckCentre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Kelsey KavicMental Health Commission of Canada, Ottawa, ON, Canada.
Sapna WadhawanMental Health Commission of Canada, Ottawa, ON, Canada.
Maureen AbbottMental Health Commission of Canada, Ottawa, ON, Canada.
Omair HusainCentre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Ishrat HusainCentre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Muhammad Akhter HamidDepartment of Paediatrics, University of Toronto, Toronto, ON, Canada.
Kwame McKenzieCentre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Yuri QuintanaDepartment of Medicine, Harvard University, Boston, MA, United States.
Farooq NaeemCentre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Centre for Addiction and Mental Health · CAMental Health Commission of Canada · CABeth Israel Deaconess Medical Center · USUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mental health Applications (Mhealth Apps) can change how healthcare is delivered. However, very little is known about the efficacy of Mhealth Apps. Currently, only minimum guidance is available in Assessment and Evaluation Tools (AETs). Therefore, this project aims to understand AET developers' perspectives and end users' experiences and opinions on "how to choose a Mhealth App". Objective: The primary objectives were: (1) obtaining stakeholder's opinions and experiences of development and use of AETs for Mhealth Apps, their weaknesses and strengths, and barriers in their implementation of Mhealth Apps; (2) the experiences of App users, their analyzation and, obstacles in the use of apps; and (3) to quantify themes related to choosing a Mhealth App. Methods: This qualitative study, used a sampling method to recruit six stakeholders (one App developer, two AET developers, an individual with lived experience of mental health illness, and two physicians) who were interviewed using a topic guide. These were examined by researchers (CT, WK, & FN) using thematic content analysis. Additionally, an anonymous online survey of 107 individuals was conducted. Findings: Our analyses revealed six main themes: (a) needs and opportunities; (b) views on Mhealth apps; (c) views & opinions on AETs; (d) implementation barriers; (e) system of evaluation and; (f) future directions. The first key concept was, all stakeholders agreed that Apps could significantly impact mental health and that end-users were unaware of mental health AETs and Apps. Secondly, due to commercial interests, end-users reliability of App evaluations requires clear conflict-free guidelines. Thirdly, AETs should be evaluated and developed through a rigorous methodology. Finally, stakeholders shared insights into future developments for AETs and Mhealth Apps. Additionally, online survey respondents chose a "health professional" as their preferred source of guidance in selecting a Mhealth app (84%) and best suited to develop guidelines (70%). Conclusion: The interviews and survey highlight the need for Mhealth Apps to be regulated and the importance of health professionals' engagement in the implementation process. Similarly, without well-defined roles for App evaluations within the health care system, it is unlikely that AETs will have wider spread use and impact without risk.

Indexed as

Mobile ApplicationsDelivery of Health CareHumansMental HealthReproducibility of ResultsTaurine2-aminoethanethiosulfonic acidTaurinedigital healthevaluationguidelinesmental healthmobile Apps

Identifiers

PMID38074730
PMCPMC10703154
OpenAlexW4388940434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.